In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Thermo Fisher Scientific Inc (NYSE: TMO) closed at $459.22 down -1.88% from its previous closing price of $468.0. In other words, the price has decreased by -$1.88 from its previous closing price. On the day, 3.23 million shares were traded. TMO stock price reached its highest trading level at $468.76 during the session, while it also had its lowest trading level at $457.405.
Ratios:
For a deeper understanding of Thermo Fisher Scientific Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.65.
HSBC Securities Downgraded its Buy to Hold on July 24, 2025, while the target price for the stock was maintained at $510.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 05 ’25 when CASPER MARC N sold 400 shares for $500.50 per share. The transaction valued at 200,201 led to the insider holds 113,762 shares of the business.
CASPER MARC N bought 400 shares of TMO for $200,201 on Sep 05 ’25. On Aug 29 ’25, another insider, Holmes Joseph R., who serves as the VP & Chief Accounting Officer of the company, sold 385 shares for $492.63 each. As a result, the insider received 189,662 and left with 2,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMO now has a Market Capitalization of 173407043584 and an Enterprise Value of 202337042432. As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.58, and their Forward P/E ratio for the next fiscal year is 18.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.71. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.01 while its Price-to-Book (P/B) ratio in mrq is 3.43. Its current Enterprise Value per Revenue stands at 4.682 whereas that against EBITDA is 18.704.
Stock Price History:
The Beta on a monthly basis for TMO is 0.77, which has changed by -0.25259596 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, TMO has reached a high of $623.77, while it has fallen to a 52-week low of $385.46. The 50-Day Moving Average of the stock is -3.16%, while the 200-Day Moving Average is calculated to be -4.08%.
Shares Statistics:
For the past three months, TMO has traded an average of 2.46M shares per day and 2401020 over the past ten days. A total of 377.61M shares are outstanding, with a floating share count of 376.99M. Insiders hold about 0.16% of the company’s shares, while institutions hold 90.63% stake in the company. Shares short for TMO as of 1757894400 were 3829062 with a Short Ratio of 1.56, compared to 1755216000 on 3821685. Therefore, it implies a Short% of Shares Outstanding of 3829062 and a Short% of Float of 1.0199999.
Dividends & Splits
According to the company, the forward annual dividend rate for TMO is 1.68, from 1.64 in the trailing year. Against a Trailing Annual Dividend Yield of 0.0035042735. The stock’s 5-year Average Dividend Yield is 0.24. The current Payout Ratio is 9.43% for TMO, which recently paid a dividend on 2025-09-15 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 1996-06-06 when the company split stock in a 3:2 ratio.
Earnings Estimates
At present, 22.0 analysts are actively evaluating the performance of Thermo Fisher Scientific Inc (TMO) in the stock market.The consensus estimate for the next quarter is $6.51, with high estimates of $6.66 and low estimates of $6.3.
Analysts are recommending an EPS of between $22.66 and $22.31 for the fiscal current year, implying an average EPS of $22.5. EPS for the following year is $24.43, with 28.0 analysts recommending between $25.87 and $23.76.
Revenue Estimates
A total of 19 analysts believe the company’s revenue will be $10.9B this quarter.It ranges from a high estimate of $11B to a low estimate of $10.83B. As of the current estimate, Thermo Fisher Scientific Inc’s year-ago sales were $10.6BFor the next quarter, 19 analysts are estimating revenue of $11.78B. There is a high estimate of $11.99B for the next quarter, whereas the lowest estimate is $11.5B.
A total of 26 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $44.15B, while the lowest revenue estimate was $43.6B, resulting in an average revenue estimate of $43.89B. In the same quarter a year ago, actual revenue was $42.88BBased on 26 analysts’ estimates, the company’s revenue will be $46B in the next fiscal year. The high estimate is $47.58B and the low estimate is $45.24B.
